Longevity AI Consortium
Awareness of utilising AI technologies within longevity and ageing research is rapidly increasing in both academia and industry. To utilise the latest AI advances and accelerate innovation and technology transfer, Ageing Research at King’s (ARK) has partnered with Biogerontology Research Foundation and our industry partners Insilico Medicine, Deep Knowledge Ventures and Ageing Analytics Agency to establish UK’s first Longevity AI Consortium (LAIC).
Modern deep learning techniques used to develop longevity and ageing predictors offer new possibilities for diverse data types. This will enable a holistic view to identify novel geroprotectors, biomarkers, drug discovery and biotechnology in the longevity, healthcare and pharmaceutical industry. With our partners, ARK and the LAIC are committed to bring together AI expertise across KCL and King’s Health Partners to explore its utility and impact for longevity and ageing research. We will employ a variety of AI-based methods to explore patterns that have significant potential to impact longevity, healthy ageing, age-related diseases and targeted therapeutics from biomedicine to social and economic sciences.
The aims of the Longevity AI Consortium include:
- Identification of novel longevity and healthy ageing biomarkers
- Accelerated diagnosis of age-related health decline, with increased accuracy
- Refining demographic and clinical methods to facilitate recruitment, retention and ongoing reappraisal.
- Development of personalised health, longevity and treatment practices
- Promoting effective healthy lifestyles for longevity, such as modifying patterns in sleep, nutrition, physical activity and environmental exposure.
Affiliated Groups at King's College London:
Institute of Psychiatry, Psychology and Neuroscience
Department of Old Age Psychiatry
Department of Neuroimaging
Department of Biostatistics
Biomarker Research and Imaging for Neuroscience (BRAIN) Centre
UK Dementia Research Institute at King's College London
Faculty of Life Sciences and Medicine
School of Biomedical Engineering & Imaging Sciences
London Medical Imaging and AI Centre for Value Based Healthcare
Centre for Stem Cells and Regenerative Medicine
Stem Cell Hotel
Faculty of Natural & Mathematical Sciences
Department of Informatics.
External Charity and Industry Partners:
Biogerontology Research Foundation
Ageing Analytics Agency
Deep Knowledge Ventures
ARK partners Insilico Medicine and Biogerontology Research Foundation (BGRF) have collaborated to realise the impact of AI for longevity research. They have recently demonstrated the disruptive potential that AI holds in terms of accelerating progress in drug discovery which has implications in the development of therapies capable of extending healthspan and reducing the incidence of age-related disease. Further information at the BGRF website.